🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07408570
Enrolling by invitation Not applicable

FREQUENCY-DEPENDENT SOLEUS REFLEX MODULATION DURING WHOLE-BODY VIBRATION

NCT07408570 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-11-30
Last updated
2026-02-13

Condition(s) studied

Healthy AdultWhole Body Vibration

Investigational drug(s) / intervention(s)

whole body vibration

whole body vibration: Whole-Body Vibration Protocol Participants will stand upright in an anatomically neutral position on the vibration platform and will be allowed to lightly hold the device's handrail to maintain balance without providing mechanical support. Vibration amplitude will be set at 2 mm. Each frequency condition will be applied for 15 s, with a 10 s rest period between trials. All WBV applications will be delivered using a Power Plate Pro5 device (Power Plate International Ltd., UK).

Study summary

Exposure to microgravity leads to pronounced impairments in neuromuscular control, postural stability, and spinal reflex regulation that cannot be attributed to muscle atrophy alone. Rather, these deficits point to a disruption of load-dependent sensorimotor mechanisms and highlight the essential role of gravitational loading of the skeleton as a critical source of sensory input for spinal motor control.

Spinal reflex behavior during upright stance has traditionally been explained primarily by muscle spindle-mediated pathways. However, this framework does not fully account for the reflex alterations observed under conditions of altered mechanical loading, including microgravity, prolonged unloading, or exposure to vibration. In parallel, advances in bone biology have identified osteocytes within the lacuno-canalicular system as highly sensitive mechanosensors that preferentially respond to dynamic loading and changes in strain rate. This insight has given rise to the concept of bone myoregulation, in which bone-derived mechanosensory signals contribute to the modulation of spinal excitability.

A defining characteristic of this process is the poroelastic nature of bone tissue. As a fluid-saturated porous medium, bone exhibits frequency-dependent mechanical behavior, such that oscillatory loading modifies both the temporal profile and magnitude of interstitial fluid flow within the lacuno-canalicular network. As a result, loading frequency is expected to influence not only the timing of reflex responses but also their amplitude. Whole-body vibration offers a controlled experimental paradigm to probe these frequency-dependent, load-sensitive mechanisms in humans.

Accordingly, the aim of the present study was to identify the whole-body vibration frequency band that most effectively induces soleus reflex responses during quiet standing, considering both reflex latency and response amplitude. Investigators hypothesized that these responses would display frequency-dependent behavior consistent with poroelastic bone-mediated myoregulation and would be modulated by individual anthropometric characteristics, with potential implications for vibration-based countermeasures under altered gravitational loading.

Eligibility

Sex
ALL
Min age
20 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy adults aged between 20 and 45 years, * Absence of regular exposure to whole-body vibration (WBV) training. Exclusion Criteria: * A history of intolerance to whole-body vibration, * Vertigo history, * Any medical or neurological condition that could be exacerbated by vibratory stimulation. All participants will provide written informed consent prior to participation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Pmr Training Hospital Bahçelievler Istanbul

More Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07408570 on ClinicalTrials.gov ↗ ← All trials in Turkey